Today: 15 May 2026

Liberty Broadband Stock Plunges 26% as Charter Earnings Jolt Merger Bet

Liberty Broadband Stock Plunges 26% as Charter Earnings Jolt Merger Bet

Liberty Broadband shares dropped about 26% Friday, mirroring a plunge in Charter Communications after Charter reported losing 120,000 internet customers last quarter, more than expected. Liberty holders are set to receive Charter stock under a pending merger, tying Liberty’s value to Charter’s share price. Charter closed down 26% at $179.04. Liberty’s Class A and C shares traded near $41.65 late in the session.
Ouster Stock Jumps as Atlanta Traffic Deal Puts BlueCity Near 2026 World Cup Sites

Ouster Stock Jumps as Atlanta Traffic Deal Puts BlueCity Near 2026 World Cup Sites

Ouster Inc shares climbed 6.7% to $28.17 Friday after announcing its BlueCity lidar traffic system will be deployed at over 30 Atlanta intersections ahead of the 2026 FIFA World Cup. The expansion, in partnership with Georgia DOT and Southern Lighting & Traffic Systems, builds on earlier installations near Mercedes-Benz Stadium. Ouster will report first-quarter results May 5.
24 April 2026
Capital One $425M Settlement Approved: Who Gets Paid and When Payouts Could Start

Capital One $425M Settlement Approved: Who Gets Paid and When Payouts Could Start

A federal judge in Alexandria approved Capital One’s $425 million class-action settlement over its 360 Savings accounts, ordering the bank to match the higher 360 Performance Savings interest rate for affected customers. Payments are set for July 21 unless appealed. The settlement covers account holders from September 2019 to June 2025. Individual payouts will reflect lost interest due to the rate gap.
24 April 2026
Hims & Hers Stock Rallies After JPMorgan Bets On Its GLP-1 Pivot

Hims & Hers Stock Rallies After JPMorgan Bets On Its GLP-1 Pivot

Hims & Hers shares jumped about 9% Friday after JPMorgan initiated coverage with an overweight rating and a $35 price target. The move comes as Hims announced access to Eli Lilly’s Zepbound and Foundayo through LillyDirect, though the company said it is not affiliated with Lilly. Hims shares recently traded at $30.70. The company serves about 2.5 million subscribers.
24 April 2026
Constellation Energy Stock Jumps as Microsoft-Backed Three Mile Island Restart Hits a Grid Fight

Constellation Energy Stock Jumps as Microsoft-Backed Three Mile Island Restart Hits a Grid Fight

PJM’s independent market monitor urged FERC to reject Constellation’s waiver request for restarting the former Three Mile Island Unit 1, now called Crane. The move threatens Constellation’s plan to supply Microsoft-linked data centers in 2027. Constellation shares rose 7.2% despite the regulatory challenge. FERC will decide whether Constellation can transfer grid rights from Eddystone units to Crane.
24 April 2026
Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus

Atomera Stock Jumps Nearly 50% After Synopsys Deal Puts GaN Chip Tech in Focus

Atomera shares surged 49% to $9.20 midday Friday after the company said it expanded its Synopsys partnership to model gallium nitride devices for RF and power chips. Trading volume topped 24 million shares, lifting Atomera’s market value to about $288 million. The announcement comes ahead of Atomera’s May 5 first-quarter results, with investors still seeking signs of commercial revenue. No financial terms were disclosed.
24 April 2026
CoreWeave CEO’s $35.8 Million Stock Sale Tests AI Cloud Rally

CoreWeave CEO’s $35.8 Million Stock Sale Tests AI Cloud Rally

CoreWeave CEO Michael Intrator sold $35.8 million in company shares this week, according to an SEC filing, after the stock’s sharp rise. The sale, under a pre-set trading plan, involved 307,693 shares at prices between $114.71 and $120.33. Shares traded at $112.46 Friday, down 4.2%. Chief strategy officer Brian Venturo also disclosed $130.4 million in sales by related entities.
StoneCo (STNE) Stock Slides as $2.53 Special Dividend Hits: What Investors Need to Know

StoneCo (STNE) Stock Slides as $2.53 Special Dividend Hits: What Investors Need to Know

StoneCo shares dropped 16.3% to $12.18 Friday after trading ex-dividend for a $2.53-per-share extraordinary cash payout, totaling about R$3.08 billion. Shareholders approved 2025 accounts and board changes, including naming Mateus Scherer Schwening CEO. The dividend follows the sale of Linx. StoneCo reported 2025 adjusted gross profit up 13.5% to R$6.3 billion and payment volume up 8.7% to R$560.9 billion.
Why Cadence Stock Is Back in Focus Before Earnings as TSMC AI Chip Push Builds

Why Cadence Stock Is Back in Focus Before Earnings as TSMC AI Chip Push Builds

Cadence shares rose 5.2% to $330.66 Friday, rebounding after a 5.21% drop Thursday. The move followed news that Cadence expanded its AI chip design collaboration with TSMC, covering advanced process nodes. Investors await Cadence’s first-quarter earnings report Monday. Rosenblatt reiterated a Buy rating and set a $360 price target.
TSMC Stock Hits Record After Taiwan Opens the Buying Door for Funds

TSMC Stock Hits Record After Taiwan Opens the Buying Door for Funds

TSMC shares closed at a record NT$2,185 in Taipei Friday, up 5.05%, after Taiwan eased single-stock limits for local equity funds and active ETFs. The rule change allows these funds to invest up to 25% in companies like TSMC, which makes up over 40% of the market. TSMC also announced a new A13 chip roadmap and expanded U.S. packaging plans. MediaTek and UniMicron shares also rose sharply.
24 April 2026
AEye Stock Jumps After Craig-Hallum Buy Rating Puts LIDR Turnaround in Focus

AEye Stock Jumps After Craig-Hallum Buy Rating Puts LIDR Turnaround in Focus

AEye Inc. shares surged over 30% Friday after Craig-Hallum initiated coverage with a buy rating and $3.50 target. The stock traded at $2.25 in early afternoon, with volume topping 97 million shares. AEye reported 2025 revenue of about $230,000 and a $34 million net loss, with 16 active customers. Paul Berton, formerly of Lucid Motors, joined as vice president of operations and quality.
US Stock Market Today: Nasdaq Hits Record as Intel AI Rally Outruns Dow

US Stock Market Today: Nasdaq Hits Record as Intel AI Rally Outruns Dow

Nasdaq climbed 1.5% to 24,805.83 and the S&P 500 gained 0.68% at mid-session Friday, while the Dow slipped 0.33%. Intel surged over 20% after projecting second-quarter revenue above estimates, sparking a rally in chip stocks. U.S. consumer sentiment hit a record low in April, keeping inflation concerns in focus. Brent crude traded at $104.62, down 0.43%.
Eos Energy Enterprises Sets Q1 Earnings Date as EOSE Stock Jumps — May 13 Is the Real Test

Eos Energy Enterprises Sets Q1 Earnings Date as EOSE Stock Jumps — May 13 Is the Real Test

Eos Energy Enterprises will report first-quarter results before the U.S. market opens May 13, after previewing revenue of $56 million to $57 million and a 17% rise in shipments. Shares traded at $7.78, up 12%, with volume at 25.6 million. Eos recently signed a joint development deal with TURBINE-X for AI power infrastructure. The company’s second battery line completed factory acceptance testing last quarter.
Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

Charter Communications shares fell 22% Friday after the company lost 120,000 internet customers in the first quarter, double last year’s loss and worse than analyst forecasts. Revenue slipped 1% to $13.6 billion; net income dropped to $1.16 billion. The stock traded at $187.65, down $54.13. Charter is still seeking California approval to close its $34.5 billion Cox Communications deal.
24 April 2026
Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s new oral weight-loss drug Foundayo was prescribed 3,707 times in its second week on the U.S. market, well below Novo Nordisk’s oral Wegovy, which saw 18,410 prescriptions in the same period after launch. Lilly shares fell about 4% following the data, while Novo Nordisk’s U.S. shares rose nearly 6%. Foundayo was approved by the FDA on April 1 and began shipping April 6.
Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

Cheetah Net Supply Chain Service Inc. shares surged Friday, trading over 2.09 billion shares after the company agreed to buy Hong Kong-based Super International Trading Limited for $4.98 million in cash. The stock rose to $0.0547, up 2.16 cents. The deal includes a $10 million annual revenue commitment from the target. Cheetah recently set up a $70 million at-the-market stock sale program.
24 April 2026
Keel Infrastructure’s Paraguay Sale Puts Former Bitfarms’ AI Data Center Bet on the Clock

Keel Infrastructure’s Paraguay Sale Puts Former Bitfarms’ AI Data Center Bet on the Clock

Keel Infrastructure Corp. sold its 70-megawatt Paso Pe site in Paraguay for about $13 million, well below the original price of up to $30 million, finalizing its exit from Latin America. The sale follows Keel’s U.S. redomiciliation and rebrand from Bitfarms as it shifts from Bitcoin mining to AI data-center infrastructure. Keel shares rose 5.4% to $3.42 in New York. The company reported a net loss of $284.5 million for 2025.
1 73 74 75 76 77 1,940

Stock Market Today

  • Madison Air Solutions Shares Up 33.9% YTD but Valuation Raises Questions
    May 15, 2026, 3:58 PM EDT. Madison Air Solutions (MAIR) shares have risen 33.9% year to date, closing at $42.51, driven by strong investor interest in the indoor air quality sector. However, its price-to-sales (P/S) ratio stands at 6.4x, significantly above the U.S. Building industry average of 2x and peer average of 3.3x, suggesting the stock may be overvalued. The P/S ratio shows investors pay $6.40 for every $1 of revenue, indicating elevated expectations. Meanwhile, a discounted cash flow (DCF) model estimates fair value at $27.48, highlighting a premium in the current price. Investors should weigh growth prospects against risks like revenue slowdown and competitive pressure before making decisions.

Latest articles

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

15 May 2026
AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
UBS Calls Time on Ambev’s Run After Brazil Beer Surge

UBS Calls Time on Ambev’s Run After Brazil Beer Surge

15 May 2026
Ambev’s São Paulo shares fell 0.25% to 15.73 reais Friday, despite UBS raising its target price but maintaining a Sell rating. First-quarter profit rose 2.1% to 3.89 billion reais, with Brazil Beer volumes hitting a record and net revenue up 9.6%. Cash flow surged 162.5% to 3.16 billion reais. Consolidated cash cost of goods sold per hectoliter climbed 8.5%.
Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

Pfizer Inc Looks to India for Growth—But Proof Remains Elusive for Investors

15 May 2026
Pfizer is increasing investment in India for cancer drugs, obesity treatments, and vaccines as it seeks growth beyond COVID-era sales. The company reported Q1 revenue of $14.5 billion, up 5%, but expects a $1.5 billion hit this year from generic competition. Shares fell 1.8% to $25.29 in New York trading. In Europe, Pfizer won expanded approval for its hemophilia drug Hympavzi.
Shares of BigBear.ai Slide as Defense AI Hype Wavers

Shares of BigBear.ai Slide as Defense AI Hype Wavers

15 May 2026
BigBear.ai shares fell about 5% to $4.16 Friday afternoon after reporting flat first-quarter revenue of $34.4 million and a wider adjusted EBITDA loss of $9.9 million. Backlog rose 14% to $281.9 million, boosted by a $53 million classified contract. The company kept its 2026 revenue forecast at $135 million to $165 million. Gross margin improved to 34.0% from 21.3% a year earlier.
Go toTop